For: |
Fan XH, Geng JZ, Wang LF, Zheng YY, Lu HY, Li J, Xu XY. |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i43/4804.htm |
Number | Citing Articles |
1 |
M. Lee, S. Oh, H. J. Lee, T.‐S. Yeum, J.‐H. Lee, S. J. Yu, H. Y. Kim, J.‐H. Yoon, H.‐S. Lee, Y. J. Kim. Telbivudine protects renal function in patients with chronic hepatitisBinfection in conjunction with adefovir‐based combination therapy. Journal of Viral Hepatitis 2014; 21(12): 873 doi: 10.1111/jvh.12217
|
2 |
Rong-Quan Fu. Combination lamivudine and adefovir versus entecavir for the treatment of naïve chronic hepatitis B patients: A pilot study. Medical Science Monitor 2013; 19: 751 doi: 10.12659/MSM.889443
|
3 |
Ma Li‐Na, Ding Xiang‐Chun, Liu Xiao‐Yan, Xu Chun‐Qiong, Shuai‐Wei Liu, Xie Yan. De novo combination therapy adefovir plus lamivudine as a treatment for women of child‐bearing age with HBeAg‐positive chronic hepatitis B Before Pregnancy. Journal of Medical Virology 2014; 86(3): 433 doi: 10.1002/jmv.23828
|
4 |
|
5 |
|